Insider Transactions Reported by 18 Insiders of Septerna, Inc.

Symbol
SEPN on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Septerna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures VI, L.P. 10%+ Owner $62.6M +$6.28M +11.2% 24 Feb 2025
Third Rock Ventures V, L.P. 10%+ Owner $54.8M 28 Oct 2024
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $8.61M 17 Jun 2025
Jeffrey Finer Chief Executive Officer, Director $2.28M +$97K +4.44% 07 Aug 2025
Daniel D. Long SVP, Drug Discovery $1.68M -$63.2K -3.63% 10 Nov 2025
Uwe Klein SVP, Biological Sciences $1.48M 18 Aug 2025
Elizabeth Bhatt President and COO $1.02M 07 Aug 2025
Alan Ezekowitz Director $813K +$608K +296% 17 Jun 2025
Ran Xiao Interim CFO $340K 24 Oct 2024
Gil M. Labrucherie Chief Financial Officer $234K +$229K +4739% 07 Aug 2025
Jake Simson Director 17 Jun 2025
Shalini Sharp Director 17 Jun 2025
Bernard Coulie Director 17 Jun 2025
Abraham Bassan Director 17 Jun 2025
Samira Shaikhly Chief People Officer 07 Aug 2025
Jae B. Kim Chief Medical Officer 07 Aug 2025
Jeffrey K. Tong Director 17 Jun 2025
Keith Michael Gottesdiener Director 25 Sep 2025

Recent Insider Transactions by Companies or Individuals for Septerna, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.